Should You Buy Biogen Stock After Its Stunning FDA Win?

Biogen stock

There are still some risks for the biotech stock. But they're a lot lower now, with its Alzheimer's disease drug likely to make billions of dollars.

Continue reading on Motley Fool

More articles about Biogen stock

Biogen stock

Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You ...

2 weeks ago by Motley Fool

There are better options for investors looking to profit from potential Alzheimer's disease treatments.

Continue reading
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You ...
Biogen stock

Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA ...

2 weeks ago by MarketWatch

Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad...

Continue reading
Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA ...
Biogen stock

Biogen shares surge 38% after FDA approves Alzheimer's drug, the ...

2 weeks ago by CNBC

The FDA approved Biogen's Alzheimer's disease drug aducanumab. It's the first drug cleared by U.S. regulators to slow cognitive decline in people living with ...

Continue reading
Biogen shares surge 38% after FDA approves Alzheimer's drug, the ...
Biogen stock

Biogen's stock soars as Alzheimer's drug costs revealed after FDA ...

2 weeks ago by Fox Business

Biogen Inc. shares were on track for their biggest gain on record after the drugmaker released pricing for its recently approved Alzheimer's drug Aduhelm.

Continue reading
Biogen's stock soars as Alzheimer's drug costs revealed after FDA ...
Biogen stock

Biogen shares surge 40% after FDA approves Alzheimer's drug, the ...

2 weeks ago by CNBC

The FDA approved Biogen's Alzheimer's disease drug aducanumab. It's the first drug cleared by U.S. regulators to slow cognitive decline in people living with ...

Continue reading
Biogen shares surge 40% after FDA approves Alzheimer's drug, the ...
Biogen stock

Biogen Stock Rockets To Record High On Alzheimer's Drug ...

2 weeks ago by Investor's Business Daily

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday and Biogen stock rocketed to a record high after trading resumed.

Continue reading
Biogen Stock Rockets To Record High On Alzheimer's Drug ...
Biogen stock

Biogen Stock Jumps on FDA Approval. What Wall Street Is Saying.

2 weeks ago by Barron's

Other biotech stocks climb as agency's action surprises even the bulls.

Continue reading
Biogen Stock Jumps on FDA Approval. What Wall Street Is Saying.
Biogen stock

​​​​​​​Biogen Alzheimer's Drug Approved in Disease Landmark

2 weeks ago by Bloomberg

Biogen Inc.'s controversial Alzheimer's disease therapy was approved by U.S. regulators, a landmark decision that stands to dramatically change treatment for ...

Continue reading
​​​​​​​Biogen Alzheimer's Drug Approved in Disease Landmark
Biogen stock

Biogen investors brace for “mother of all binary events” as FDA is set ...

2 weeks ago by Seeking Alpha

Biogen shares have reached the highest level in the year so far as the investors e eagerly await the FDA decision on aducanumab, the experimental...

Continue reading
Biogen investors brace for “mother of all binary events” as FDA is set ...
Biogen stock

Biogen shares surge 60% after FDA approves Alzheimer's drug, the ...

2 weeks ago by CNBC

The FDA approved Biogen's Alzheimer's disease drug aducanumab. It's the first drug cleared by U.S. regulators to slow cognitive decline in people living with ...

Continue reading
Biogen shares surge 60% after FDA approves Alzheimer's drug, the ...
Biogen stock

Why Biogen Stock Is On Fire Today

2 weeks ago by Motley Fool

The biotech's controversial Alzheimer's disease drug got a green light from the FDA.

Continue reading
Why Biogen Stock Is On Fire Today
Biogen stock

Biogen Traders Poised for FDA Verdict on Alzheimer's Treatment

2 weeks ago by Yahoo Finance

(Bloomberg) -- Investors are getting emboldened with Biogen Inc. shares climbing more than 9% over the last four sessions ahead of a regulatory decision on ...

Continue reading
Biogen Traders Poised for FDA Verdict on Alzheimer's Treatment
Biogen stock

Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know ...

2 weeks ago by Investor's Business Daily

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.

Continue reading
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know ...
Biogen stock

Biogen Stock Gains Before Anticipated FDA Decision

2 weeks ago by Barron's

The Food and Drug Administration is due to disclose whether it is approving the company's Alzheimer's disease therapy, called aducanumab.

Continue reading
Biogen Stock Gains Before Anticipated FDA Decision